2048 Ventures

Overview

2048 Ventures is a thesis-driven early-stage venture capital firm based in NYC and Boston[1][2]. Founded in 2018[4], the firm writes pre-seed and seed stage checks ranging from $500K to $3M[1]. The company focuses its investment activity on vertical AI, deep tech, health, and biotech sectors[3].

States it is 'based in NYC and Boston' [1]

The company's own site places it in New York: Text explicitly states '2048 Ventures is a thesis-driven early stage venture capital firm based in NYC and Boston.'. [6]

2048 Ventures was founded by Alex Iskold and Paul Sethi and announced itself publicly in May 2019. [7]

The firm writes $500K to $3M checks, leads pre-seed and seed rounds, and goes from first meeting to a commitment to lead in 10 to 15 business days. [12]

It invests in systems of record, infrastructure and API companies across Vertical AI, Deep Tech, Health, and Bio. [13]

2048 Ventures describes itself as a thesis-driven early stage venture capital firm based in NYC and Boston. [14]

Funding history

The firm raised a first fund of $27 million, announced on May 8, 2019. [8]

2048 Ventures announced an oversubscribed $67 million Fund II in January 2022. [9]

2048 Ventures closed an oversubscribed Fund III of $82,048,000 as of January 29, 2026. [10]

Growth & traction

The firm states that the 50 companies it backed in Fund I have raised more than $200M and are valued at over $1B. [11]

The firm's team page profiles 10 people, including three partners: Alex Iskold, Zann Ali and Julie Wolf. [15]